Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination through Braster telemedical centers. The company was founded in 2008 and is headquartered in Ozarów Mazowiecki, Poland.
Research context
Braster S.A. appears in PyInvesting’s Warsaw Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- PLN
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Braster S.A. is currently in a long term uptrend where the price is trading 9.0% above its 200 day moving average.
Braster S.A.'s total revenue sank by 66.3% to $21K since the same quarter in the previous year.
Its net income has increased by 62.3% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 69.2% to $-3M since the same quarter in the previous year.
Based on the above factors, Braster S.A. gets an overall score of 3/5.